AbbVie Demonstrates Leadership in Gastroenterology and Hepatology with New Data and LateBreaking Studies to be Presented at Digestive Disease WeekÂ

NORTH CHICAGO Ill. May 4 2017 PRNewswire AbbVie NYSE ABBV a global biopharmaceutical company today announced that data from 20 abstracts in gastroenterology and hepatology programs will be presented at Digestive Disease Week DDW 2017 May 6 9 in Chicago....